Isotopic composition of foraminifera from sediments of DSDP Legs 3, 6-9, 17

Oxygen isotopic compositions of the tests of planktonic foraminifera from several Deep Sea Drilling Project sites provide a general picture of low-latitude marine temperatures from Maastrichtian time to the present. Bottom temperatures determined from the isotopic compositions of benthonic foraminifera are interpreted as being indicative of high-latitude surface temperatures. Prior to the beginning of middle Miocene time, high- and low-latitude temperatures changed in parallel fashion. Following an apparently small and short-lived drop in temperature near the Tertiary-Cretaceous boundary, temperatures remained warm and relatively constant through Paleocene and early and middle Eocene time; bottom temperatures then were on the order of 12°C. A sharp temperature drop in late Eocene time was followed by a more gradual lowering of temperature, culminating in a late Oligocene high-latitude temperature minimum of about 4°C. A temperature rise through early Miocene time was followed in middle Miocene time by a sudden divergence of high- and low-latitude temperatures: high-latitude temperatures dropped dramatically, perhaps corresponding to the onset of major glaciation in Antarctica, but low-latitude temperatures remained constant or perhaps increased. This uncoupling of high-and low-latitude temperatures is postulated to be related to the establishment of a circum-Antarctic circulation similar to that of today. A further drop in high-latitude temperatures in late Pliocene time probably signaled the onset of a major increase in polar glaciation, including extensive sea-ice formation. Early Miocene, small-amplitude (1 per mil) sympathetic fluctuations in isotopic compositions of planktonic and benthonic foraminifera have been identified. These have a period of several hundred thousand years. Superimposed upon these are much more rapid and smaller fluctuations (0.2 to 0.5 per mil) with a period of about 80000 to 90000 yr. This is similar to the period observed for Pleistocene isotopic temperature fluctuations. In low latitudes, much smaller vertical temperature gradients seem to have existed during Maastrichtian and Paleogene time than exist at present. The absence of a sharply defined thermocline during early Tertiary time is also suggested.

Benthic oxygen isotope and dust flux record from ODP Site 108-659 in the North Atlantic

High-resolution benthic oxygen isotope and dust flux records from Ocean Drilling Program site 659 have been analyzed to extend the astronomically calibrated isotope timescale for the Atlantic from 2.85 Ma back to 5 Ma. Spectral analysis of the delta18O record indicates that the 41-kyr period of Earth's orbital obliquity dominates the Pliocene record. This is shown to be true regardless of fundamental changes in the Earth's climate during the Pliocene. However, the cycles of Sahelian aridity fluctuations indicate a shift in spectral character near 3 Ma. From the early Pliocene to 3 Ma, the periodicities were dominantly precessional (19 and 23 kyr) and remained strong until 1.5 Ma. Subsequent to 3 Ma, the variance at the obliquity period (41 kyr) increased. The timescale tuned to precession suggests that the Pliocene was longer than previously estimated by more than 0.5 m.y. The tuned ages for the magnetic boundaries Gauss/Gilbert and Top Cochiti are about 6-8% older than the ages of the conventional timescale. A major phase of Pliocene northern hemisphere ice growth occurred between 3.15 Ma and 2.5 Ma. This was marked by a gradual increase in glacial Atlantic delta18O values of 1per mil and an increase in amplitude variations by up to 1.5 per mil, much larger than in the Pacific deepwater record (site 846). The first maxima occured in cold stages G6-96 between 2.7 Ma and 2.45 Ma. Prior to 3 Ma, the isotope record is characterized by predominantly low amplitude fluctuations (< 0.7 per mil). When obliquity forcing was at its minimum between 4.15 and 3.6 Ma and during the Kaena interval, delta18O amplitude fluctuations were minimal. From 4.9 to 4.3 Ma, the delta18O values decreased by about 0.5 per mil, reaching a long-term minimum at 4.15 Ma, suggesting higher deepwater temperatures or a deglaciation. Deepwater cooling and/or an increase in ice volume is indicated by a series of short-term delta18O fluctuations between 3.8 and 3.6 Ma.

Transverse momentum and pseudorapidity distributions of charged hadrons in pp collisions at sqrt(s) = 0.9 and 2.36 TeV

Measurements of inclusive charged-hadron transverse-momentum and pseudorapidity distributions are presented for proton-proton collisions at sqrt(s) = 0.9 and 2.36 TeV. The data were collected with the CMS detector during the LHC commissioning in December 2009. For non-single-diffractive interactions, the average charged-hadron transverse momentum is measured to be 0.46 +/- 0.01 (stat.) +/- 0.01 (syst.) GeV/c at 0.9 TeV and 0.50 +/- 0.01 (stat.) +/- 0.01 (syst.) GeV/c at 2.36 TeV, for pseudorapidities between -2.4 and +2.4. At these energies, the measured pseudorapidity densities in the central region, dN(charged)/d(eta) for |eta|

Structural and photoluminescence properties of In-0.9(Ga/Al)(0.1)As self-assembled quantum dots on InP substrate

Self-assembled In0.9Ga0.1As, In0.9Al0.1As, and InAs quantum dots (QD) were fabricated in an InAlAs matrix lattice-matched to an InP substrate by molecular beam epitaxy. Preliminary characterizations were performed using transmission electron microscopy, photoluminescence, and reflection high-energy electron diffraction. Experimental results reveal clear differences in QD formation, size distribution, and luminescence between the InAs and In-0.9(Ga/Al)(0.1)As samples, which show the potential of introducing ternary compositions to adjust the structural and optical properties of QDs on an InP substrate. (C) 2000 American Institute of Physics. [S0021-8979(00)10213-0].

Luminescence properties of Y0.9-xGdxEu0.1Al3(BO3)(4) (0 <= x <= 0.9) phosphors prepared by spray pyrolysis process

Starting from metal nitrate aqueous solutions and H3BO3, Y0.9-xGdxEu0.1Al3(BO3)(4) (0 <= x <= 0.9) phosphors were synthesized by spray pyrolysis followed by annealing at high temperature. The obtained phosphor particles have spherical morphology with size in the range 0.5-2 mu m. Independent of the x values in Y0.9-xGdxEu0.1Al3(BO3)(4) (0 <= x <= 0.9) phosphors, the Eu3+ ion shows its characteristic D-5(0), (1)-F-7(J) (J = 0, 1, 2, 3, 4) transitions with D-5(0)-F-7(2) red emission (612 nm) as the most prominent group. The photoluminescence intensity of phosphors increases with the increase of x value in Y0.9-xGdxEu0.1Al3(BO3)(4) (0 <= x <= 0.9) due to an energy migration process like Gd3+-(Gd3+)(n)-Eu3+ that occurred in the host materials.

Conservantes em Formulações de Cloreto de Sódio 0,9% para Aplicação Tópica em Pediatria

As formulações de cloreto de sódio 0,9%, são na sua grande maioria utilizadas com bastante frequência sobretudo na população pediátrica. Tanto os cuidadores como os próprios profissionais de saúde as reconhecem e avaliam como um componente essencial para os cuidados de saúde desta população. No entanto, o grave problema destas formulações reside no facto de muitos dos consumidores após a sua utilização apresentarem reacções adversas, que não são justificáveis se apenas da composição da formulação fizerem parte água purificada e cloreto de sódio. Assim deve ser tida em conta a composição de cada apresentação farmacêutica, a fim de se averiguar quanto à presença de conservantes potencialmente perigosos e para deste modo alertar os possíveis consumidores destes produtos. O principal objectivo deste estudo foi a análise e avaliação da rotulagem e folheto de instruções das formulações de cloreto de sódio 0,9% para aplicação tópica em pediatria, a fim de se averiguar a utilização de conservantes na sua formulação e por conseguinte a sua conformidade para comercialização. Com o auxílio de uma check-list, foram avaliadas 34 apresentações de venda livre de formulações de cloreto de sódio 0,9% para aplicação tópica, no período de Janeiro a Março de 2014. Das 34 apresentações farmacêuticas analisadas, apenas uma dasapresentações não se encontrava descrita como dispositivo médico, mas sim como produto cosmético. Contudo quanto à marcação CE de conformidade, esta encontrava-se devidamente aposta em 94% das apresentações. No que às indicações terapêuticas diz respeito e como seria expectável, na sua maioria estas apresentações destinam-se em 51% dos casos para utilização nasal e em 33% dos casos para utilização oftálmica, sendo o modo de apresentação em gotas (88%) o mais encontrado para comercialização. Quanto à utilização de conservantes, constatou-se uma grande omissão e alguma imprecisão quanto às informações contidas na rotulagem e/ou folheto de instruções das formulações analisadas, expondo assim os indivíduos mais susceptíveis e em especial a população pediátrica ao risco de reacções adversas e que por vezes podem ser fatais. Por outro lado também podem ocorrer complicações aquando do uso inadvertido destasformulações com conservantes, por portadores de lentes de contacto ou sem a devida esterilidade para utilização oftálmica. Assim apesar de o soro fisiológico não ser considerado um medicamento, mas sim um dispositivo médico, deve ser contudo utilizado com algumas precauções, sobretudo nesta população pediátrica e sempre que possível aconselhado por um profissional treinado e consciente da problemática que os conservantes usados nestas formulações podem causar quando utilizados indevidamente.

Synthesis optimization, structural evolution and optical properties of Y(0.9)Er(0.1)Al(3)(BO(3))(4) nanopowders obtained by soft chemistry methods

This paper describes the structural evolution of Y(0.9)Er(0.1)Al(3)(BO(3))(4) nanopowders using two soft chemistry routes, the sol-gel and the polymeric precursor methods. Differential scanning calorimetry, differential thermal analyses, thermogravimetric analyses, X-ray diffraction, Fourier-transform infrared, and Raman spectroscopy techniques have been used to study the chemical reactions between 700 and 1200 degrees C temperature range. From both methods the Y(0.9)Er(0.1)Al(3)(BO(3))(4) (Er:YAB) solid solution was obtained almost pure when the powdered samples were heat treated at 1150 degrees C. Based on the results, a schematic phase formation diagram of Er:YAB crystalline solid solution was proposed for powders from each method. The Er:YAB solid solution could be optimized by adding a small amount of boron oxide in excess to the Er:YAB nominal composition. The nanoparticles are obtained around 210 nm. Photoluminescence emission spectrum of the Er:YAB nanocrystalline powders was measured on the infrared region and the Stark components of the (4)I(13/2) and (4)I(15/2) levels were determined. Finally, for the first time the Raman spectrum of Y(0.9)Er(0.1)Al(3)(BO(3))(4) crystalline phase is also presented. (C) 2008 Elsevier Masson SAS. All rights reserved.

Aspects of solid state formation and properties of Sn(0.9)Ti(0.1)O(2) system doped with CoO and Nb(2)O(5)

The effect of calcination temperature during the formation of the solid solution Sn(0.9)Ti(0.1)O(2) doped with 1.00 mol % CoO and 0.05 mol % Nb(2)O(5) is presented. The structural characteristics of this system were studied using X-ray diffraction, and the changes in phase formation were analyzed using the Rietveld method. With an increase in calcination temperature, there is increasing miscibility of Ti into the (Ti,Sn)O(2) phase and near 1000 degrees C, and the remaining TiO(2) (anatase) was transformed into the rutile phase. The sintering process, monitored using dilatometry, suggests two mass transport mechanisms, one activated close to 900 degrees C associated with the presence of TiO(2) (anatase) and the second mechanism, occurring between 1200 and 1300 degrees C, is attributed to a faster grain boundary diffusion caused by oxygen vacancies. (C) 2008 International Centre for Diffraction Data.

Repeatability of corrosion parameters for titanium-molybdenum alloys in 0.9% NaCl solution

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Charged particle transverse momentum spectra in pp collisions at √s = 0:9 and 7 TeV

The charged particle transverse momentum (pT) spectra are presented for pp collisions at √s = 0:9 and 7TeV. The data samples were collected with the CMS detector at the LHC and correspond to integrated luminosities of 231 μb-1 and 2.96 pb-1, respectively. Calorimeter-based high-transverse-energy triggers are employed to enhance the statistical reach of the high-pT measurements. The results are compared with leading and next-toleading order QCD and with an empirical scaling of measurements at different collision energies using the scaling variable xT - 2pT=ps over the pT range up to 136 GeV/c. Using a combination of xT scaling and direct interpolation at fixed pT, a reference transverse momentum spectrum at √s = 2:76TeV is constructed, which can be used for studying high-pT particle suppression in the dense QCD medium produced in heavy-ion collisions at that centre-of-mass energy. Copyright CERN.

Measurement of the underlying event activity in pp collisions at √s = 0.9 and 7 TeV with the novel jet-area/median approach

The first measurement of the charged component of the underlying event using the novel jet-area/median approach is presented for proton-proton collisions at centre-of-mass energies of 0.9 and 7 TeV. The data were recorded in 2010 with the CMS experiment at the LHC. A new observable, sensitive to soft particle production, is introduced and investigated inclusively and as a function of the event scale defined by the transverse momentum of the leading jet. Various phenomenological models are compared to data, with and without corrections for detector effects. None of the examined models describe the data satisfactorily. © 2012 SISSA.

Cloreto de sódio a 0,9%, adicionado ou não de dexametasona, intrapleural, na prevenção de aderências pulmonares após toracotomia intercostal em cães

Pulmonary adhesions in dogs are a common sequel after surgical intervention, undermining any interventions. This study aimed to determine in dogs, the efficacy of sodium chloride solution 0.9% with or without dexamethasone in order to prevent adhesions after intercostal thoracotomy. Fifteen dogs were separated into three groups of five animals, A, B and C and underwent thoracotomy in the fifth left intercostal space. Three other dogs were submitted to a previous study. In the dogs of Group A it was performed only a thoracotomy and thoracorraphy; in group B, it was performed a thoracotomy, thoracorraphy and injection into the pleural cavity of isotonic sodium chloride (10ml) and dexamethasone (1mg kg-1). In the dogs of the group C, it was performed the thoracotomy thoracorraphy and injected isotonic sodium chloride (10ml kg-1) into the pleural cavity. After 15 days of thoracotomy, it was performed transdiaphragmatic thoracocospy to determine the presence and score of adhesions between the lung and chest wall. The results demonstrated the presence of adhesions in the majority of group A and reduced or no adhesions in the other groups. For statistical evaluation, it was pplied the chi-square test with significance level of 5% (P≤0.05). The sodium chloride solution 0.9% with or without dexamethasone in the pleural space prevented or reduced lung adhesions after intercostal thoracotomy.

Uso intrapleural de solução de cloreto de sódio 0,9%, adicionada ou não de dexametasona, na prevenção de aderências pulmonares após toracotomia intercostal em cães

Pós-graduação em Cirurgia Veterinária - FCAV

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at root s=0.9 and 2.36 TeV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Endectocide activity of a pour-on formulation containing 1.5 per cent ivermectin +0.5 per cent abamectin in cattle

The present work aimed to evaluate, through ten different studies, the therapeutic efficacy of a new pour-on formulation, containing 1.5 per cent ivermectin +0.5 per cent abamectin, against parasites of cattle. Results obtained on trials against Rhipicephalus (Boophilus) microplus showed that the pour-on combination of 1.5 per cent ivermectin +0.5 per cent abamectin obtained superior efficacy indexes against this ectoparasite, when compared with formulations containing 0.5 per cent ivermectin, 1 per cent ivermectin and the combination of 1 per cent abamectin +20 per cent levamisole. The results of efficacy of the ivermectin+abamectin and the 0.5 per cent ivermectin against Haematobia irritans were similar. Against Cochliomyia hominivorax larvae, all pour-on formulations tested (1.5 per cent ivermectin +0.5 per cent abamectin, 0.5 per cent ivermectin and 0.5 per cent abamectin), as well as 1 per cent doramectin administered subcutaneously, were considered ineffective. Cattle medicated with 1.5 per cent ivermectin +0.5 per cent abamectin, pour-on, remained free from parasitism by Dermatobia hominis larvae during 42 days (96 per cent efficacy), while values superior to 90 per cent were obtained by 0.5 per cent ivermectin (92 per cent) and 0.5 per cent abamectin (93 per cent) until the 42nd and 35th days post treatment, respectively. Against Haemonchus placei and Oesophagostomum radiatum, the pour-on of ivermectin+abamectin showed better efficacy than the 0.5 per cent ivermectin and 0.5 per cent abamectin. As to Cooperia punctata, there was no difference regarding efficacy results obtained by the avermectins combination and abamectin. The pour-on combination of 1.5 per cent ivermectin +0.5 per cent abamectin obtained high efficacy against R. (B.) microplus, D. hominis and some species of cattle gastrointestinal helminths when compared with formulations of 0.5 per cent ivermectin and 0.5 per cent abamectin administered through the same route.